Home › Lupus
Pag-aaral pangklinika para sa Lupus na nagre-recruit sa U.S.
73 pag-aaral para sa Lupus ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY18 pag-aaral
- Durham, NC12 pag-aaral
- Houston, TX12 pag-aaral
- Miami, FL10 pag-aaral
- Washington, DC10 pag-aaral
- Tampa, FL9 pag-aaral
- Philadelphia, PA9 pag-aaral
- Chicago, IL8 pag-aaral
- Santa Monica, CA8 pag-aaral
- Los Angeles, CA8 pag-aaral
- Boston, MA8 pag-aaral
- Clearwater, FL8 pag-aaral
- Charlotte, NC7 pag-aaral
- San Diego, CA7 pag-aaral
- Plantation, FL7 pag-aaral
- Oklahoma City, OK7 pag-aaral
- Memphis, TN7 pag-aaral
- Buena Park, CA7 pag-aaral
- Dallas, TX6 pag-aaral
- Atlanta, GA6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- Aurora, CO6 pag-aaral
- Hollywood, FL6 pag-aaral
- St. Louis, MO5 pag-aaral
- Cleveland, OH5 pag-aaral
- Syracuse, NY5 pag-aaral
- Lake Charles, LA5 pag-aaral
- Jackson, TN5 pag-aaral
- New Orleans, LA5 pag-aaral
- Orlando, FL5 pag-aaral
- Cicero, IL5 pag-aaral
- Fullerton, CA5 pag-aaral
- New Rochelle, NY4 pag-aaral
- Columbus, OH4 pag-aaral
- Louisville, KY4 pag-aaral
- Phoenix, AZ4 pag-aaral
- Kansas City, KS4 pag-aaral
- Charleston, SC4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Frisco, TX4 pag-aaral
Ayos sa estado
- Alabama5 pag-aaral
- Arizona7 pag-aaral
- California27 pag-aaral
- Colorado8 pag-aaral
- District of Columbia5 pag-aaral
- Florida23 pag-aaral
- Georgia9 pag-aaral
- Illinois14 pag-aaral
- Indiana4 pag-aaral
- Iowa6 pag-aaral
- Kansas5 pag-aaral
- Kentucky4 pag-aaral
- Louisiana9 pag-aaral
- Maryland10 pag-aaral
- Massachusetts9 pag-aaral
- Michigan10 pag-aaral
- Minnesota5 pag-aaral
- Missouri8 pag-aaral
- Nebraska3 pag-aaral
- New Jersey6 pag-aaral
- New York26 pag-aaral
- North Carolina20 pag-aaral
- Ohio11 pag-aaral
- Oklahoma7 pag-aaral
- Pennsylvania13 pag-aaral
- South Carolina5 pag-aaral
- Tennessee13 pag-aaral
- Texas26 pag-aaral
- Utah4 pag-aaral
- Virginia4 pag-aaral
- Washington5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Kababaihan · Na-update Set 28, 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07607964A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Nagre-recruitPhase 1/2
Edad 10 hanggang 29 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05440422Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07201558Anifrolumab Pregnancy Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Kababaihan · Na-update Set 18, 2026 · NCT07049653A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07409181A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Nagre-recruitPhase 2
Edad 16 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06987565Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Nagre-recruitPhase 4
Edad 18 hanggang 130 · Kababaihan · Na-update Set 16, 2026 · NCT06594068Study of Systemic Lupus Erythematosus
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 3 hanggang 120 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT00001372HEALTH Home Urinalysis Testing
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07823478A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Nagre-recruitPhase 1
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06916806A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07355218Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06975787A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Nagre-recruitPhase 2
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07332481A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT05835310A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06897930A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
Nagre-recruitPhase 4
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06875960A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Nagre-recruitPhase 3
Edad 16 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06617325Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.